Your kidneys are working tirelessly throughout the day to keep your system clean from unwanted waste products and fluids.

The discontinuation comes after the investigational drug, volenrelaxin, failed a related heart failure study in an ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, published in Science, from researchers at the Perelman School of Medicine at the ...

Like most people who have been diagnosed with a life-threatening disease, Ruel Bautista is still trying to come to terms with ...

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...

Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...

Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

It showed that 1 mg Ozempic led to a 24 per cent reduced risk of worsening kidney disease and kidney failure (end-stage ...